Comparison of different advanced oxidation processes for the removal of amoxicillin in aqueous solution.

Amoxicillin (AMX) is a widely used penicillin-type antibiotic whose presence in the environment has been investigated. In this work, the degradation of the AMX in aqueous solutions by ozonation, ozonation with UV radiation (O3/UV), homogeneous catalytic ozonation (O3/Fe2+) and homogeneous photocatalytic ozonation (O3/Fe2+/UV) was investigated. The performance results have been compared in terms of removal of amoxicillin and total organic carbon (mineralization efficiency). In all processes, complete amoxicillin degradation was obtained after 5 min. However, low mineralization was achieved. For the best available process, the potential toxicity of AMX intermediates formed after ozonation was examined using a Fish Embryo Toxicity test. Results reveal that O3 in alkaline solution and O3/Fe2+/UV provide the highest mineralization rates. Ecotoxicity showed that no acute toxicity was observed during the exposure period of 96 h.

Determination of pharmaceutical compounds in hospital wastewater and their elimination by advanced oxidation processes.

This study investigates the mineralization efficiency, i.e. removal of total organic carbon (TOC) in hospital wastewater by direct ozonation, ozonation with UV radiation (O3/UV), homogeneous catalytic ozonation (O3/Fe2+) and homogeneous photocatalytic ozonation (O3/Fe2+/UV). The influence of pH and reaction time was evaluated. For the best process, toxicity and degradation efficiency of the selected pharmaceutical compounds (PhCs) were determined. The results showed that the PhCs detected in the hospital wastewater were completely degraded when the mineralization efficiency reached 54.7% for O3/UV with 120 minutes of reaction time using a rate of 1.57 g O3 h-1. This process also achieved a higher chemical oxygen demand removal efficiency (64.05%), an increased aromaticity reduction efficiency (81%) and a toxicity reduction.

Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.

BACKGROUND AIMS: The purpose of this study was to investigate whether the secretome of human adipose-derived stem cells (hADSC) affects human glioblastoma (GBM) cancer stem cell (CSC) subpopulation or has any influence on drug resistance and cell migration, evaluating the safety of hADSCs for novel cancer therapies. METHODS: hADSCs were maintained in contact with fresh culture medium to produce hADSCs conditioned medium (CM). GBM U87 cells were cultured with CM and sphere formation, expression of genes related to resistance and CSCs-MGMT, OCT4, SOX2, NOTCH1, MSI1-and protein expression of OCT4 and Nanog were analyzed. The influence of hADSC CM on GBM resistance to temozolomide (TMZ) was evaluated by measuring cumulative population doubling and hADSC CM influence on tumor cell migration was analyzed using transwell assay. RESULTS: hADSC CM did not alter CSC-related features such as sphere-forming capacity and expression of genes related to CSC. hADSC CM treatment alone did not change proliferation rate of U87 cells and, most important, did not alter the response of tumor cells to TMZ. However, hADSC CM secretome increased the migration capacity of glioblastoma cells. DISCUSSION: hADSC CM neither induced an enrichment of CSCs in U87 cells population nor interfered in the response to TMZ in culture. Nevertheless, paracrine factors released by hADSCs were able to modulate glioblastoma cells migration. These findings provide novel information regarding the safety of using hADSCs against cancer and highlight the importance of considering hADSC-tumor cells interactions in tumor microenvironment in the design of novel cell therapies.